Parmax Pharma EGM: All 4 resolutions passed with 100 percent approval
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
EGM on July 2, 2026: all 4 resolutions passed with 100 percent approval. Items approved: increase in authorised share capital and MOA amendment (ordinary), new Articles of Association (special), preferential issue of 31,37,586 equity shares to non-promoters, and 21,45,145 convertible warrants to non-promoters. Polling: 23.36 lakh votes from 37.41 lakh outstanding shares (62.44 percent). Promoters (11.52 lakh) voted fully in favour. Only 1 public vote against on two items.
Capital expansion via preferential issue and warrants will dilute existing shareholders. Non-promoter investors taking stakes. Positive for fundraising but dilutive.